Peter Oppelt
Johannes Kepler University of Linz
ORCID: 0000-0001-6685-1762Also affiliated with Kepler Universitätsklinikum
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial”.
Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more
Emma Y. Travis, Susan K. Wong, Cathryn Collopy, Kate McClannahan, Amanda J. Ortmann +12 more
Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more
Rajwant S. Mahal, Theresa Tharakan, Cathryn Collopy, Dorina Kallogjeri, Wade L. Thorstad +6 more
Ann Marie Egloff, Alexander B. Afeyan, Jacquelyn O. Wolff, Zexiang Zeng, Rebecca D. Chernock +34 more
Keith M. Skubitz, Seth Maliske, Sarah L. Mott, Hilary Dietz, Angela C. Hirbe +11 more
Kate Anthony, Bonnie Higgins, Peter Oppelt, Omar Shebl, Irene Tiemann‐Boege +4 more